Health News: [diabetes ]: FDA OKs first-of-a-kind diabetes drug from J&J

Yahoo! Health   |  My alerts   |   Edit Alert Friday, Mar 29, 2013 04:11 PM EDT

Health News : diabetes - News from Yahoo !   FDA approves Johnson & Johnson diabetes drug, canagliflozin Fri, 29 Mar, 2013 12:47 PM PDT By Toni Clarke (Reuters) - FDA has approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. The U.S. Food and Drug Administration approved the drug, Invokana, after data showed it was effective in lowering blood sugar in patients with Ty... Continue reading FDA approves first-in-class diabetes pill from J&J that flushes blood sugar via urine Fri, 29 Mar, 2013 12:39 PM PDT WASHINGTON - The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients' urine.... Continue reading

Health News : diabetes - News from other sources.   FDA OKs first-of-a-kind diabetes drug from J&J Fri, 29 Mar, 2013 01:09 PM PDT The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar Continue reading FDA OKs first-of-its-kind diabetes drug from J&J Fri, 29 Mar, 2013 01:00 PM PDT WASHINGTON (AP) — The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients' urine. Continue reading FDA Approves J&J's Invokana Diabetes Treatment Fri, 29 Mar, 2013 12:39 PM PDT FDA Approves J&J's Invokana Diabetes Treatment Continue reading U.S. FDA approves Johnson & Johnson diabetes drug Fri, 29 Mar, 2013 12:37 PM PDT U.S. health regulators have approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. The U.S. Food and Drug Administration approved the drug, Invokana, after data showed it was effective in lowering blood sugar in patients with Type 2 Continue reading JJ Wins U.S. Approval for First in Diabetes Drug Class Fri, 29 Mar, 2013 12:32 PM PDT Johnson & Johnson, the world's largest seller of health-care products, won approval for the first in a new family of diabetes drugs for managing blood sugar. Continue reading FDA approves Johnson & Johnson's novel diabetes drug Fri, 29 Mar, 2013 12:31 PM PDT The medicine is designed to lower blood sugar levels by eliminating more sugar in the urine Continue reading FDA clears Johnson & Johnson type 2 diabetes drug Invokana Fri, 29 Mar, 2013 12:28 PM PDT WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Johnson & Johnson's experimental type 2 diabetes drug Invokana to help patients control their blood sugar. Continue reading FDA Approves First SGLT2 Inhibitor For Diabetes Fri, 29 Mar, 2013 12:26 PM PDT The FDA said today that it had approved canaglifozin (Invokana, Johnson & Johnson), the first of a new class of diabetes drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Canaglifozin is indicated to improve glycemic control in adults with type 2 diabetes in conjunction with die... Continue reading

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.